ORbital Atherectomy for Lesion Preparation in Patients With Chronic Limb-threatening ischEmia
NCT: NCT07270562 · NOT_YET_RECRUITING
Brief Summary
ORACLE is a Europe-wide study that will follow 250 people with critical limb-threatening ischemia (CLTI). It aims to see how well orbital atherectomy (OA) works in real-life practice. OA is a procedure that uses a tiny spinning tool to gently remove hard calcium from inside an artery, helping to open the vessel so other treatments-like balloons or stents-can work better. The study focuses on people who have heavily calcified arteries in the femoropopliteal or infrapopliteal areas of the leg.
Frequently Asked Questions
What is ORbital Atherectomy for Lesion Preparation in Patients With Chronic Limb-threatening ischEmia?
ORbital Atherectomy for Lesion Preparation in Patients With Chronic Limb-threatening ischEmia is a clinical trial registered under NCT07270562. Current status: NOT_YET_RECRUITING.
What is the status of NCT07270562?
The current status of NCT07270562 (ORbital Atherectomy for Lesion Preparation in Patients With Chronic Limb-threatening ischEmia) is: NOT_YET_RECRUITING.
When did ORbital Atherectomy for Lesion Preparation in Patients With Chronic Limb-threatening ischEmia start?
ORbital Atherectomy for Lesion Preparation in Patients With Chronic Limb-threatening ischEmia started on 2026-08.
Official Source
View on ClinicalTrials.gov →Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.